Target intelligence / Profile preview

Bradykinin receptor B2 (B2R) (B2R)

Target
B2R
Molecular classification
G protein-coupled receptor, Receptor, Peptide receptor, Rhodopsin-like GPCR
01

Overview

The Bradykinin receptor B2 (B2R) is a G protein-coupled receptor that serves as the primary mediator for the physiological and pharmacological effects of bradykinin and kallidin [UniProt P30551]. These peptides are generated endogenously from kininogens by the action of kallikrein enzymes within the kallikrein-kinin system [IUPHAR Guide to Pharmacology]. Unlike the B1 receptor, which is typically induced during tissue injury or inflammation, the B2 receptor is constitutively expressed in various tissues, including the vascular endothelium, smooth muscle, and sensory neurons [PubMed: 15128905]. Activation of the B2 receptor triggers signaling pathways that lead to potent vasodilation, increased vascular permeability, and the stimulation of nociceptors, making it a central player in the inflammatory response and blood pressure regulation [PubMed: 15128905]. In clinical pathology, the B2 receptor is a major therapeutic target for hereditary angioedema (HAE), a condition characterized by excessive bradykinin production leading to severe, potentially life-threatening localized swelling [StatPearls: Hereditary Angioedema]. Pharmacological targeting of the B2 receptor primarily involves the use of selective antagonists, such as icatibant, which provide rapid relief during acute HAE attacks by blocking the binding of endogenously generated kinins [PubMed: 21633164]. Beyond HAE, the receptor is also implicated in other inflammatory conditions, cardiovascular regulation, and the pathophysiology of certain viral infections like COVID-19 [PubMed: 32735825]. Safety concerns for B2 receptor modulation include potential hypotension and interactions with ACE inhibitors, which can exacerbate bradykinin-mediated side effects [PubMed: 11588311].

Other names
BDKRB2BK-2 receptorBK2RB2 bradykinin receptorBradykinin B2 receptorBradykinin B2 receptor – via endogenously generated kinins
02

Mechanism of action

Competitive antagonism of the B2 receptor to block the binding of endogenously generated bradykinin and kallidin, thereby preventing vasodilation, edema, and pain [PubMed: 21633164].

03

Biological functions

Signal transductionVasodilationInflammationVascular permeabilityPain sensationSmooth muscle contraction
04

Disease associations

Hereditary angioedemaInflammationCardiovascular diseasePainAsthmaDiabetic nephropathyCOVID-19
05

Safety considerations

Hypotension [IUPHAR]Injection site reactions [PubMed: 21633164]Potential for angioedema when combined with ACE inhibitors [PubMed: 11588311]Dizziness
06

Interacting drugs

Icatibant

4 more in the full profile.

07

Biomarkers

C1-esterase inhibitor (C1-INH) levels [StatPearls]C4 complement levels [StatPearls]Plasma bradykinin levels [PubMed: 23544414]

Beyond the preview

Go deeper on Bradykinin receptor B2 (B2R) (B2R).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bradykinin receptor B2 (B2R) (B2R).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call